Analysis of a study of menses induction using a vaginal suppository containing 3.0 mg 15(S)-15-methyl-PGF2 alpha methyl ester.
D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D006801:Humans; D008600:Menstruation-Inducing Agents / Q000627:therapeutic use*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011460:Prostaglandins F / Q000097:blood; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D013488:Suppositories / Q000627:therapeutic use; D014621:Vagina
D006063:Chorionic Gonadotropin; D008600:Menstruation-Inducing Agents; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D013488:Suppositories; D011374:Progesterone